These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 19325227)

  • 21. Nucleoside analog studies indicate mechanistic differences between RNA-editing adenosine deaminases.
    Mizrahi RA; Phelps KJ; Ching AY; Beal PA
    Nucleic Acids Res; 2012 Oct; 40(19):9825-35. PubMed ID: 22885375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insights into ADAR gene complement, expression patterns, and RNA editing landscape in Chlamys farreri.
    Bortoletto E; Rosani U; Sakaguchi A; Yoon J; Nagasawa K; Venier P
    Fish Shellfish Immunol; 2024 Aug; 151():109743. PubMed ID: 38964433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. irCLASH reveals RNA substrates recognized by human ADARs.
    Song Y; Yang W; Fu Q; Wu L; Zhao X; Zhang Y; Zhang R
    Nat Struct Mol Biol; 2020 Apr; 27(4):351-362. PubMed ID: 32203492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reovirus-mediated induction of ADAR1 (p150) minimally alters RNA editing patterns in discrete brain regions.
    Hood JL; Morabito MV; Martinez CR; Gilbert JA; Ferrick EA; Ayers GD; Chappell JD; Dermody TS; Emeson RB
    Mol Cell Neurosci; 2014 Jul; 61():97-109. PubMed ID: 24906008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ADARs and editing: The role of A-to-I RNA modification in cancer progression.
    Fritzell K; Xu LD; Lagergren J; Öhman M
    Semin Cell Dev Biol; 2018 Jul; 79():123-130. PubMed ID: 29146145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure and sequence determinants required for the RNA editing of ADAR2 substrates.
    Dawson TR; Sansam CL; Emeson RB
    J Biol Chem; 2004 Feb; 279(6):4941-51. PubMed ID: 14660658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional conservation in human and Drosophila of Metazoan ADAR2 involved in RNA editing: loss of ADAR1 in insects.
    Keegan LP; McGurk L; Palavicini JP; Brindle J; Paro S; Li X; Rosenthal JJ; O'Connell MA
    Nucleic Acids Res; 2011 Sep; 39(16):7249-62. PubMed ID: 21622951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenosine deaminases acting on RNA, RNA editing, and interferon action.
    George CX; Gan Z; Liu Y; Samuel CE
    J Interferon Cytokine Res; 2011 Jan; 31(1):99-117. PubMed ID: 21182352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA binding by ADAR3 inhibits adenosine-to-inosine editing and promotes expression of immune response protein MAVS.
    Raghava Kurup R; Oakes EK; Manning AC; Mukherjee P; Vadlamani P; Hundley HA
    J Biol Chem; 2022 Sep; 298(9):102267. PubMed ID: 35850307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative Activity of Adenosine Deaminase Acting on RNA (ADARs) Isoforms for Correction of Genetic Code in Gene Therapy.
    Azad MTA; Qulsum U; Tsukahara T
    Curr Gene Ther; 2019; 19(1):31-39. PubMed ID: 30426900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases.
    Yang W; Chendrimada TP; Wang Q; Higuchi M; Seeburg PH; Shiekhattar R; Nishikura K
    Nat Struct Mol Biol; 2006 Jan; 13(1):13-21. PubMed ID: 16369484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA editing by ADAR2 is metabolically regulated in pancreatic islets and beta-cells.
    Gan Z; Zhao L; Yang L; Huang P; Zhao F; Li W; Liu Y
    J Biol Chem; 2006 Nov; 281(44):33386-94. PubMed ID: 16956888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ADAR1 RNA deaminase limits short interfering RNA efficacy in mammalian cells.
    Yang W; Wang Q; Howell KL; Lee JT; Cho DS; Murray JM; Nishikura K
    J Biol Chem; 2005 Feb; 280(5):3946-53. PubMed ID: 15556947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral.
    Samuel CE
    Virology; 2011 Mar; 411(2):180-93. PubMed ID: 21211811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenosine Deaminases That Act on RNA (ADARs).
    Wang Y; Zheng Y; Beal PA
    Enzymes; 2017; 41():215-268. PubMed ID: 28601223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antagonistic and stimulative roles of ADAR1 in RNA silencing.
    Nishikura K; Sakurai M; Ariyoshi K; Ota H
    RNA Biol; 2013 Aug; 10(8):1240-7. PubMed ID: 23949595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ADAR2 A-->I editing: site selectivity and editing efficiency are separate events.
    Källman AM; Sahlin M; Ohman M
    Nucleic Acids Res; 2003 Aug; 31(16):4874-81. PubMed ID: 12907730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased RNA editing and inhibition of hepatitis delta virus replication by high-level expression of ADAR1 and ADAR2.
    Jayan GC; Casey JL
    J Virol; 2002 Apr; 76(8):3819-27. PubMed ID: 11907222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Requirement of dimerization for RNA editing activity of adenosine deaminases acting on RNA.
    Cho DS; Yang W; Lee JT; Shiekhattar R; Murray JM; Nishikura K
    J Biol Chem; 2003 May; 278(19):17093-102. PubMed ID: 12618436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ADAR RNA editing in human disease; more to it than meets the I.
    Gallo A; Vukic D; Michalík D; O'Connell MA; Keegan LP
    Hum Genet; 2017 Sep; 136(9):1265-1278. PubMed ID: 28913566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.